STATI, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 1.111
EU - Europa 423
AS - Asia 173
AF - Africa 7
SA - Sud America 6
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.723
Nazione #
US - Stati Uniti d'America 1.100
IT - Italia 159
SE - Svezia 101
CN - Cina 78
IN - India 70
DE - Germania 50
FI - Finlandia 22
IE - Irlanda 22
FR - Francia 21
SG - Singapore 16
GB - Regno Unito 14
CA - Canada 11
RO - Romania 9
UA - Ucraina 7
BE - Belgio 6
RU - Federazione Russa 5
AR - Argentina 4
BG - Bulgaria 3
IR - Iran 3
TG - Togo 3
ZA - Sudafrica 3
AU - Australia 2
CL - Cile 2
KZ - Kazakistan 2
OM - Oman 2
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
KG - Kirghizistan 1
NL - Olanda 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
Totale 1.723
Città #
Fairfield 145
Ashburn 113
Chandler 103
Houston 73
Cambridge 68
Seattle 66
Wilmington 64
Woodbridge 60
Ann Arbor 56
Beijing 40
Princeton 38
San Paolo di Civitate 35
Rome 31
Lawrence 23
Plano 23
Dublin 22
Boston 19
Millbury 17
Andover 10
Milan 10
Norwalk 9
San Diego 9
Bremen 8
Fremont 8
Redwood City 7
Brussels 6
Toronto 6
Dearborn 5
Grafing 5
Hefei 5
Jinan 5
Kunming 5
Ottawa 5
Villasanta 5
Federal 4
London 4
Mumbai 4
Pune 4
Singapore 4
Southend 4
Washington 4
Bühl 3
Castel d'Ario 3
Dallas 3
Falls Church 3
Helsinki 3
Lomé 3
Marcallo con Casone 3
Melegnano 3
Phoenix 3
San Mateo 3
Sofia 3
Castelnuovo Magra 2
Chengdu 2
Des Moines 2
Fuzhou 2
Guangzhou 2
Jinhua 2
Muizenberg 2
Muscat 2
Nanjing 2
Quistello 2
Ridder 2
Zungri 2
Arnsberg 1
Bangalore 1
Baotou 1
Bishkek 1
Boardman 1
Changsha 1
Chicago 1
Contigliano 1
Crocetta del Montello 1
Dossenheim 1
Fiumicino 1
Genoa 1
Hebei 1
Jacksonville 1
Leawood 1
Lecce 1
Lisbon 1
Mcallen 1
Menaggio 1
Monmouth Junction 1
Munich 1
Nailloux 1
Nanchang 1
Nanning 1
New York 1
Nâves-parmelan 1
Padova 1
Paris 1
Quezon City 1
Reggio Calabria 1
Rockville 1
Santiago 1
Shanghai 1
Shenyang 1
Silverton 1
Silvi 1
Totale 1.225
Nome #
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC) 113
The role of BMI and age in chemotherapy-induced amenorrhea (CIA) in premenopausal breast cancer (PBC) patients treated with adjuvant FEC100 with or without docetaxel (D) 79
Bevacizumab in glioblastomas: lights and shadows 77
A 68-year-old Caucasian man presenting with urinary bladder lymphoepithelioma: a case report 75
Multimodal treatment for local recurrent malignant gliomas: resurgery and/or reirradiation followed by chemotherapy 74
Early clear cell “sugar” lung cancer management: a case report and a brief literature review 71
Subcutaneous metastases from colon cancer: A case report 68
Correlation between fertility drugs use and malignant melanoma incidence: the state of the art 68
Fertility drugs, reproductive strategies and ovarian cancer risk 63
Fertility drugs and breast cancer risk 63
Patient age is an independent risk factor of relapse of differentiated thyroid carcinoma and Improves the performance of the American Thyroid Association Stratification System 62
Single-center experience with pegfilgrastim (P) and lenograstim (L) in nonmetastatic breast cancer (NMBC) patients (pts) during adjuvant FEC100 or sequential FEC100 plus DOCETAXEL100 (D100) 56
Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS mutant non-small cell lung cancer patients. a retrospective analysis 54
Nonpegylated liposomal doxorubicin (nPLD) in neoadjuvant treatment of local advanced breast cancer (LABC) patients (pts) 53
Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: the Italian NSCLC expanded access program 53
Carcinoma polmonare non a piccole cellule (NSCLC) non squamoso metastatico. l’era della terapia di combinazione 52
Cell-free circulating tumor DNA(ctDNA) analysis by next generation sequencing(NGS) panel in non small cell lung cancer patients(NSCLC): implications in clinical practice. XX Congresso Nazionale AIOM 2018 (Poster D18) 48
BODY MASS INDEX (BMI) AND AMENORRHEA IN PREMENOPAUSAL BREAST CANCER PATIENTS (PBC) TREATED WITH ADJUVANT ANTRACYCLINE AND CYCLOPHOSPAMIDE CHEMOTHERAPY (CT) 47
Brain metastases in EGFR-positive non-small cell lung cancer. the way to the sanctuary becomes less winding 47
Immunotherapy in refractory SCLC. the caterpillar struggling to become a butterfly 45
EFFICACY AND SAFETY PROFILES OF PEGFILGRASTIM (P) AND LENOGRASTIM (L) IN NON METASTATIC BREAST CANCER (NMBC) PATIENTS RECEIVING ADJUVANT FEC100 41
Correlation between bmi and chemotherapy related amenorrhea (cra) in premenopausal breast cancer patients (pbcp) 34
Effect of bone metastases on immunotherapy efficacy in pretreated advanced non small cell lung cancer (NSCLC). 33
Correlation among different KRAS alterations, genetic co-mutations and PDL1 expression in patients treated with immunotherapy in metastatic NSCLC 33
Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with Nivolumab in the Italian NSCLC expanded access programme. 31
Come valutare l’impatto del dolore episodico intenso (DEI) sulla qualità di vita (QV) nei pazienti oncologici? XIV Congresso Nazionale SICP Rimini 2017. (Abstract 373) 31
null 29
Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: a critical review of published data 29
Lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer patients (nmbcp) 28
PROGNOSTIC VALUE OF CIRCULATING TUMOR CELLS IN PATIENTS WITH METASTATIC BREAST CANCER AND METASTATIC PROSTATE CANCER 28
Neoplasie utero - Carcinoma della cervice uterina - Carcinoma dell’endometrio 28
null 27
Incidence of amenorrhea in premenopausal women with breast cancer (BC) undergoing chemotherapy (CT) with antracyclines (A), cyclophosfamide (C) and docetaxel (D) 27
Results of multilevel containment measures to better protect lung cancer patients from COVID-19. the IEO model 26
Fears and perception of the impact of COVID-19 on patients with lung cancer. A mono-institutional survey 26
Predictive Role of Serum Thyroglobulin after Surgery and before Radioactive Iodine Therapy in Patients with Thyroid Carcinoma 22
null 20
Incidence of chemotherapy (CT) induced amenorrhea in premenopausal patients (pts) with breast cancer (BC) following adjuvant anthracycline (A), cyclophosphamide (C), and taxane (T) 20
null 18
Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer 18
Efficacy, safety and cost-effectiveness (ce) analysis of lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer (bc) patients 14
Non pegylated liposomal doxorubicin (npld) in neoadjuvant treatment of local advanced breast cancer (labc) 10
Prexasertib, a checkpoint kinase inhibitor: from preclinical data to clinical development 2
Totale 1.843
Categoria #
all - tutte 4.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.902


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019104 0 0 0 0 0 0 0 0 0 20 45 39
2019/2020476 48 9 3 15 21 28 103 69 79 51 25 25
2020/2021174 26 25 8 14 8 15 6 25 23 19 3 2
2021/2022364 5 11 35 18 53 11 2 41 33 15 70 70
2022/2023422 78 107 29 23 44 40 11 19 55 1 9 6
2023/2024181 21 26 20 18 25 41 5 5 2 18 0 0
Totale 1.843